Armata Pharmaceuticals (ARMP) Capital Expenditures Growth (1y) (2016 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,384,976.65 Bn | 1,384,976.64 Bn | - | - |
| 2 | Alterity Therapeutics | 777,208.84 Bn | 777,208.81 Bn | - | - |
| 3 | Legend Biotech | 2,801.00 Bn | 2,800.10 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,226.01 Bn | 2,225.95 Bn | - | - |
| 5 | Akari Therapeutics | 605.66 Bn | 605.66 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 110.17 Bn | 102.92 Bn | 2.59 Bn | 227.76% |
| 7 | Regeneron Pharmaceuticals | 66.86 Bn | 58.11 Bn | 3.31 Bn | 0.57% |
| 8 | Evaxion A | 65.12 Bn | 65.10 Bn | - | - |
| 9 | Alnylam Pharmaceuticals | 39.94 Bn | 36.94 Bn | 959.66 Mn | 143.40% |
| 10 | Armata Pharmaceuticals | 301.92 Mn | 297.17 Mn | - | -36.36% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -36.36% |
| Dec 31, 2025 | 167.53% |
| Sep 30, 2025 | -28.82% |
| Jun 30, 2025 | -89.09% |
| Mar 31, 2025 | -60.40% |
| Dec 31, 2024 | -103.21% |
| Sep 30, 2024 | -90.32% |
| Jun 30, 2024 | 515.32% |
| Mar 31, 2024 | -87.56% |
| Dec 31, 2023 | 627.47% |
| Sep 30, 2023 | 171.41% |
| Jun 30, 2023 | -80.46% |
| Mar 31, 2023 | 751.69% |
| Dec 31, 2022 | -299.56% |
| Sep 30, 2022 | 122.34% |
| Jun 30, 2022 | 479.59% |
| Mar 31, 2022 | -20.81% |
| Dec 31, 2021 | -37.70% |
| Sep 30, 2021 | 618.52% |
| Jun 30, 2021 | -28.21% |
| Mar 31, 2021 | 186.54% |
| Dec 31, 2020 | 1,642.86% |
| Sep 30, 2020 | 224.62% |
| Jun 30, 2020 | 116.67% |
| Mar 31, 2020 | -26.76% |
| Dec 31, 2019 | -94.63% |
| Sep 30, 2019 | -141.94% |
| Dec 31, 2018 | 2,072.22% |
| Sep 30, 2018 | 369.70% |
| Dec 31, 2017 | 38.46% |
| Sep 30, 2017 | 13.79% |
| Jun 30, 2017 | -98.40% |
| Mar 31, 2017 | -95.54% |
| Dec 31, 2016 | -74.00% |
| Sep 30, 2016 | -75.00% |
| Jun 30, 2016 | 1,288.89% |